跳至主要内容
临床试验/NCT01193439
NCT01193439已完成不适用

Safety of Thoracoscopy in Patients With High Risk

Eskisehir Osmangazi University1 个研究点 分布在 1 个国家目标入组 355 人开始时间: 2002年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
355
试验地点
1
主要终点
Number of Participants with Adverse Events as a Measure of Safety and Tolerability

研究概览

简要总结

Medical thoracoscopy can be performed for diagnostic as well as therapeutic purposes. Thoracoscopy in the diagnosis of pleural diseases is highly sensitive for detecting pleural neoplasia with negative pleural fluid cytology and in the diagnosis of tuberculosis. The indication of thoracoscopy in patients with pleural effusion has been optimized. In some studies medical thoracoscopy has been claimed a useful diagnostic tool with a very low rate of complications. However the investigators do not know its safety on high risk patients. Because many patients having suspected malignancy have bed conditions due to other health problems such as coronary heart diseases, COPD, arrythmia, hypoxemia. In this study the investigators aimed to test the safety of medical thoracoscopy in the patients with high risk for complications.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
20 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with exudative pleural effusion

排除标准

  • Patients without pleural effusion

结局指标

主要结局

Number of Participants with Adverse Events as a Measure of Safety and Tolerability

时间窗: 6 years

All participants will have been followed for side effects of medical thoracoscopy. All side effects established in the special forms designed for this study. Side effects measured and recorded according to each characteristic such as pain, air leakege, pneumothorax, empyema, local infection, haemorragy etc.

次要结局

未报告次要终点

研究者

发起方
Eskisehir Osmangazi University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Muzaffer Metintas

MD

Eskisehir Osmangazi University

研究点 (1)

Loading locations...

相似试验